Microbiome Sequencing Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the microbiome sequencing market looks promising with opportunities in drug discovery, genetic screening, disease diagnosis research, and personalized medicine. The global microbiome sequencing market is expected to grow with a CAGR of 17%-19% from 2020 to 2025. The major drivers for this market are increasing focus on human microbiome therapy, rising government initiatives for microbiome research, and growing research activities for early disease diagnosis.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global microbiome sequencing market report, please download the report brochure.
In this market, sanger sequencing is the largest sequencing technology segment of microbiome sequencing , whereas pharmaceutical and biotechnology is the largest end user. Growth in various segments of the microbiome sequencing market are given below:
The study includes trends and forecast for the global microbiome sequencing market by sequencing technology, component, laboratory type, application, end user, and region as follows:
By Sequencing Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that sanger sequencing will remain the largest sequencing technology segment over the forecast period, as it is preferred more by researchers because of higher accuracy than other technologies.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period due to increasing prevalnce of cancer and increasing demand for personlized genomics.
North America will remain the largest region over the forecast period due to rising research activies related to genomics, surge in number of research studies on cancer & inherited rare diseases, and increasing government support related to microbiome sequencing in the region.
Features of the Global Microbiome Sequencing Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global microbiome sequencing market by technology (sanger sequencing, high-throughput sequencing (SBS, SBL, shotgun sequencing, TGS, RNA sequencing, WGS, and others), and third-generation sequencing), component (reagents & kits and instruments (liquid handling instruments, cytometers, imaging devices, and microplate reader)), application (drug discovery, genetic screening, disease diagnosis research, personalized medicine, and others), laboratory type (dry labs and wet labs), end user (pharmaceutical & biotechnology, academic centers & research institutes, contract research organizations, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global microbiome sequencing market?
Q.5 What are the business risks and threats to the global microbiome sequencing market?
Q.6 What are the emerging trends in this microbiome sequencing market and the reasons behind them?
Q.7 What are some changing demands of customers in this microbiome sequencing market?
Q.8 What are the new developments in this microbiome sequencing market? Which companies are leading these developments?
Q.9 Who are the major players in this microbiome sequencing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this microbiome sequencing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global microbiome sequencing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Sequencing Technology (Sanger Sequencing, High-Throughput Sequencing (SBS, SBL, Shotgun Sequencing, TGS, RNA Sequencing, WGS, and Others), and Third-Generation Sequencing), Component (Reagents & Kits and Instruments (Liquid Handling Instruments, Cytometers, Imaging Devices, and Microplate Reader)), Applications (Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others), Laboratory Type (Dry Labs and Wet Labs), and End User (Pharmaceutical & Biotechnology, Academic Centers & Research Institutes, Contract Research Organizations, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the microbiome sequencing market looks promising with opportunities in drug discovery, genetic screening, disease diagnosis research, and personalized medicine. The global microbiome sequencing market is expected to grow with a CAGR of 17%-19% from 2020 to 2025. The major drivers for this market are increasing focus on human microbiome therapy, rising government initiatives for microbiome research, and growing research activities for early disease diagnosis.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global microbiome sequencing market report, please download the report brochure.
In this market, sanger sequencing is the largest sequencing technology segment of microbiome sequencing , whereas pharmaceutical and biotechnology is the largest end user. Growth in various segments of the microbiome sequencing market are given below:
The study includes trends and forecast for the global microbiome sequencing market by sequencing technology, component, laboratory type, application, end user, and region as follows:
By Sequencing Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Sanger Sequencing
- High-throughput Sequencing
- Sequencing by Synthesis (SBS)
- Sequencing by Ligation (SBL)
- Shotgun Sequencing
- Targeted Gene Sequencing (TGS)
- RNA (Ribonucleic Acid) Sequencing
- Whole Genome Sequencing (WGS)
- Others
- Third-Generation Sequencing
- Reagents and Kits
- Instruments
- Liquid Handling Instruments
- Cytometers
- Imaging Devices
- Microplate Reader
- Dry Labs
- Wet Labs
- Drug Discovery
- Genetic Screening
- Disease Diagnosis Research
- Personalized Medicine
- Others
- Pharmaceutical and Biotechnology
- Academic Centers and Research Institutes
- Contract Research Organizations
- Others
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that sanger sequencing will remain the largest sequencing technology segment over the forecast period, as it is preferred more by researchers because of higher accuracy than other technologies.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period due to increasing prevalnce of cancer and increasing demand for personlized genomics.
North America will remain the largest region over the forecast period due to rising research activies related to genomics, surge in number of research studies on cancer & inherited rare diseases, and increasing government support related to microbiome sequencing in the region.
Features of the Global Microbiome Sequencing Market
- Market Size Estimates: Global microbiome sequencing market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global microbiome sequencing market size by various segments, such as sequencing technology, component, laboratory type, application, and end user in terms of value.
- Regional Analysis: Global microbiome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different sequencing technology, component, laboratory type, application, end user, and region for the global microbiome sequencing market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global microbiome sequencing market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global microbiome sequencing market by technology (sanger sequencing, high-throughput sequencing (SBS, SBL, shotgun sequencing, TGS, RNA sequencing, WGS, and others), and third-generation sequencing), component (reagents & kits and instruments (liquid handling instruments, cytometers, imaging devices, and microplate reader)), application (drug discovery, genetic screening, disease diagnosis research, personalized medicine, and others), laboratory type (dry labs and wet labs), end user (pharmaceutical & biotechnology, academic centers & research institutes, contract research organizations, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global microbiome sequencing market?
Q.5 What are the business risks and threats to the global microbiome sequencing market?
Q.6 What are the emerging trends in this microbiome sequencing market and the reasons behind them?
Q.7 What are some changing demands of customers in this microbiome sequencing market?
Q.8 What are the new developments in this microbiome sequencing market? Which companies are leading these developments?
Q.9 Who are the major players in this microbiome sequencing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this microbiome sequencing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global microbiome sequencing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Sequencing Technology (Sanger Sequencing, High-Throughput Sequencing (SBS, SBL, Shotgun Sequencing, TGS, RNA Sequencing, WGS, and Others), and Third-Generation Sequencing), Component (Reagents & Kits and Instruments (Liquid Handling Instruments, Cytometers, Imaging Devices, and Microplate Reader)), Applications (Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others), Laboratory Type (Dry Labs and Wet Labs), and End User (Pharmaceutical & Biotechnology, Academic Centers & Research Institutes, Contract Research Organizations, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Microbiome Sequencing Market Trends and Forecast
3.3: Global Microbiome Sequencing Market by Sequencing Technology
3.3.1: Sanger Sequencing
3.3.2: High-throughput Sequencing
3.3.2.1: Sequencing by Synthesis (SBS)
3.3.2.2: Sequencing by Ligation (SBL)
3.3.2.3: Shotgun Sequencing
3.3.2.4: Targeted Gene Sequencing (TGS)
3.3.2.5: RNA Sequencing
3.3.2.6: Whole Genome Sequencing (WGS)
3.3.2.7: Others
3.3.3: Third-Ggeneration Sequencing
3.4: Global Microbiome Sequencing Market by Component
3.4.1: Reagents and Kits
3.4.2: Instruments
3.4.2.1: Liquid Handling Instruments
3.4.2.1: Cytometers
3.4.2.2: Imaging Devices
3.4.2.3: Microplate Reader
3.5: Global Microbiome Sequencing Market by Laboratory Type
3.5.1: Dry Labs
3.5.2: Wet Labs
3.6: Global Microbiome Sequencing Market by Application
3.6.1: Drug Discovery
3.6.2: Genetic Screening
3.6.3: Disease Diagnosis Research
3.6.4: Personalized Medicine
3.6.5: Others
3.7: Global Microbiome Sequencing Market by End User
3.7.1: Pharmaceutical and Biotechnology
3.7.2: Academic Centers and Research Institutes
3.7.3: Contract Research Organizations
3.7.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Microbiome Sequencing Market by Region
4.2: North American Microbiome Sequencing Market
4.2.1: Market by Sequencing Technology: Sanger Sequencing, High-throughput Sequencing, and Third-Generation Sequencing
4.2.2: Market by Component: Reagents & Kits and Instruments
4.2.3: Market by Laboratory Type: Dry Labs and Wet Labs
4.2.4: Market by Application: Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others
4.2.5: Market by End User: Pharmaceutical and Biotechnology, Academic Centers and Research Institutes, Contract Research Organizations, and Others
4.2.6: The United States Microbiome Sequencing Market
4.2.7: The Canadian Microbiome Sequencing Market
4.2.8: The Mexican Microbiome Sequencing Market
4.3: European Microbiome Sequencing Market
4.3.1: Market by Sequencing Technology: Sanger Sequencing, High-throughput Sequencing, and Third-Generation Sequencing
4.3.2: Market by Component: Reagents & Kits and Instruments
4.3.3: Market by Laboratory Type: Dry Labs and Wet Labs
4.3.4: Market by Application: Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others
4.3.5: Market by End User: Pharmaceutical and Biotechnology, Academic Centers and Research Institutes, Contract Research Organizations, and Others
4.3.6: The Microbiome Sequencing Market of United Kingdom
4.3.7: The German Microbiome Sequencing Market
4.3.8: The French Microbiome Sequencing Market
4.4: APAC Microbiome Sequencing Market
4.4.1: Market by Sequencing Technology: Sanger Sequencing, High-throughput Sequencing, and Third-Generation Sequencing
4.4.2: Market by Component: Reagents & Kits and Instruments
4.4.3: Market by Laboratory Type: Dry Labs and Wet Labs
4.4.4: Market by Application: Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others
4.4.5: Market by End User: Pharmaceutical and Biotechnology, Academic Centers and Research Institutes, Contract Research Organizations, and Others
4.4.6: The Chinese Microbiome Sequencing Market
4.4.7: The Indian Microbiome Sequencing Market
4.4.8: The Japanese Microbiome Sequencing Market
4.5: ROW Microbiome Sequencing Market
4.5.1: Market by Sequencing Technology: Sanger Sequencing, High-throughput Sequencing, and Third-Generation Sequencing
4.5.2: Market by Component: Reagents & Kits and Instruments
4.5.3: Market by Laboratory Type: Dry Labs and Wet Labs
4.5.4: Market by Application: Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others
4.5.5: Market by End User: Pharmaceutical and Biotechnology, Academic Centers and Research Institutes, Contract Research Organizations, and Others
4.5.6: Brazilian Microbiome Sequencing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Microbiome Sequencing Market by Sequencing Technology
7.1.2: Growth Opportunities for the Global Microbiome Sequencing Market by Component
7.1.3: Growth Opportunities for the Global Microbiome Sequencing Market by Laboratory Type
7.1.4: Growth Opportunities for the Global Microbiome Sequencing Market by Application
7.1.5: Growth Opportunities for the Global Microbiome Sequencing Market by End User
7.1.6: Growth Opportunities for the Global Microbiome Sequencing Market by Region
7.2: Emerging Trends in the Global Microbiome Sequencing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Microbiome Sequencing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiome Sequencing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific Inc.
8.2: Illumina Inc.
8.3: Qiagen NV
8.4: Molzym GmbH & Co. KG
8.5: Novogene Corporation, Inc.
8.6: Allele Pty Ltd.
8.7: Baseclear BV
8.8: BGI Group
8.9: Biolog Inc.
8.10: Biomathematica SAS
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Microbiome Sequencing Market Trends and Forecast
3.3: Global Microbiome Sequencing Market by Sequencing Technology
3.3.1: Sanger Sequencing
3.3.2: High-throughput Sequencing
3.3.2.1: Sequencing by Synthesis (SBS)
3.3.2.2: Sequencing by Ligation (SBL)
3.3.2.3: Shotgun Sequencing
3.3.2.4: Targeted Gene Sequencing (TGS)
3.3.2.5: RNA Sequencing
3.3.2.6: Whole Genome Sequencing (WGS)
3.3.2.7: Others
3.3.3: Third-Ggeneration Sequencing
3.4: Global Microbiome Sequencing Market by Component
3.4.1: Reagents and Kits
3.4.2: Instruments
3.4.2.1: Liquid Handling Instruments
3.4.2.1: Cytometers
3.4.2.2: Imaging Devices
3.4.2.3: Microplate Reader
3.5: Global Microbiome Sequencing Market by Laboratory Type
3.5.1: Dry Labs
3.5.2: Wet Labs
3.6: Global Microbiome Sequencing Market by Application
3.6.1: Drug Discovery
3.6.2: Genetic Screening
3.6.3: Disease Diagnosis Research
3.6.4: Personalized Medicine
3.6.5: Others
3.7: Global Microbiome Sequencing Market by End User
3.7.1: Pharmaceutical and Biotechnology
3.7.2: Academic Centers and Research Institutes
3.7.3: Contract Research Organizations
3.7.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Microbiome Sequencing Market by Region
4.2: North American Microbiome Sequencing Market
4.2.1: Market by Sequencing Technology: Sanger Sequencing, High-throughput Sequencing, and Third-Generation Sequencing
4.2.2: Market by Component: Reagents & Kits and Instruments
4.2.3: Market by Laboratory Type: Dry Labs and Wet Labs
4.2.4: Market by Application: Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others
4.2.5: Market by End User: Pharmaceutical and Biotechnology, Academic Centers and Research Institutes, Contract Research Organizations, and Others
4.2.6: The United States Microbiome Sequencing Market
4.2.7: The Canadian Microbiome Sequencing Market
4.2.8: The Mexican Microbiome Sequencing Market
4.3: European Microbiome Sequencing Market
4.3.1: Market by Sequencing Technology: Sanger Sequencing, High-throughput Sequencing, and Third-Generation Sequencing
4.3.2: Market by Component: Reagents & Kits and Instruments
4.3.3: Market by Laboratory Type: Dry Labs and Wet Labs
4.3.4: Market by Application: Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others
4.3.5: Market by End User: Pharmaceutical and Biotechnology, Academic Centers and Research Institutes, Contract Research Organizations, and Others
4.3.6: The Microbiome Sequencing Market of United Kingdom
4.3.7: The German Microbiome Sequencing Market
4.3.8: The French Microbiome Sequencing Market
4.4: APAC Microbiome Sequencing Market
4.4.1: Market by Sequencing Technology: Sanger Sequencing, High-throughput Sequencing, and Third-Generation Sequencing
4.4.2: Market by Component: Reagents & Kits and Instruments
4.4.3: Market by Laboratory Type: Dry Labs and Wet Labs
4.4.4: Market by Application: Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others
4.4.5: Market by End User: Pharmaceutical and Biotechnology, Academic Centers and Research Institutes, Contract Research Organizations, and Others
4.4.6: The Chinese Microbiome Sequencing Market
4.4.7: The Indian Microbiome Sequencing Market
4.4.8: The Japanese Microbiome Sequencing Market
4.5: ROW Microbiome Sequencing Market
4.5.1: Market by Sequencing Technology: Sanger Sequencing, High-throughput Sequencing, and Third-Generation Sequencing
4.5.2: Market by Component: Reagents & Kits and Instruments
4.5.3: Market by Laboratory Type: Dry Labs and Wet Labs
4.5.4: Market by Application: Drug Discovery, Genetic Screening, Disease Diagnosis Research, Personalized Medicine, and Others
4.5.5: Market by End User: Pharmaceutical and Biotechnology, Academic Centers and Research Institutes, Contract Research Organizations, and Others
4.5.6: Brazilian Microbiome Sequencing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Microbiome Sequencing Market by Sequencing Technology
7.1.2: Growth Opportunities for the Global Microbiome Sequencing Market by Component
7.1.3: Growth Opportunities for the Global Microbiome Sequencing Market by Laboratory Type
7.1.4: Growth Opportunities for the Global Microbiome Sequencing Market by Application
7.1.5: Growth Opportunities for the Global Microbiome Sequencing Market by End User
7.1.6: Growth Opportunities for the Global Microbiome Sequencing Market by Region
7.2: Emerging Trends in the Global Microbiome Sequencing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Microbiome Sequencing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiome Sequencing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific Inc.
8.2: Illumina Inc.
8.3: Qiagen NV
8.4: Molzym GmbH & Co. KG
8.5: Novogene Corporation, Inc.
8.6: Allele Pty Ltd.
8.7: Baseclear BV
8.8: BGI Group
8.9: Biolog Inc.
8.10: Biomathematica SAS
